Literature DB >> 7718491

Neuropeptide Y immunoreactivity of a projection from the lateral thalamic nucleus to the optic tectum of the leopard frog.

A M Chapman1, E A Debski.   

Abstract

Using rhodamine-labelled latex beads as a retrograde tracer, we have shown that a subset of the neurons projecting from the lateral thalamic nucleus to the optic tectum of the leopard frog are neuropeptide Y-like immunoreactive (NPY-IR). In juvenile frogs, approximately twice as many lateral thalamic nucleus cells from this area project to the ipsilateral tectum as project to the contralateral tectum. NPY-IR cells make up 25% of the projection to the ipsilateral tectum and 13% of the projection to the contralateral tectum. The ipsilateral NPY-IR projection from the lateral nucleus was present in tadpoles and was similar in its characteristics to that found in the juvenile frog. However, the contralateral tectal projection was virtually nonexistent in these animals. The results of these experiments suggest that NPY from the lateral nucleus is released into the ipsilateral tectal neuropil in both the developing and adult frog.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718491     DOI: 10.1017/s0952523800007264

Source DB:  PubMed          Journal:  Vis Neurosci        ISSN: 0952-5238            Impact factor:   3.241


  3 in total

1.  Genome-wide census and expression profiling of chicken neuropeptide and prohormone convertase genes.

Authors:  K R Delfino; B R Southey; J V Sweedler; S L Rodriguez-Zas
Journal:  Neuropeptides       Date:  2009-12-14       Impact factor: 3.286

2.  Anatomical characterization of subcortical descending projections to the inferior colliculus in mouse.

Authors:  Mili B Patel; Stacy Sons; Georgiy Yudintsev; Alexandria M H Lesicko; Luye Yang; Gehad A Taha; Scott M Pierce; Daniel A Llano
Journal:  J Comp Neurol       Date:  2016-10-21       Impact factor: 3.215

Review 3.  I'll take the low road: the evolutionary underpinnings of visually triggered fear.

Authors:  James A Carr
Journal:  Front Neurosci       Date:  2015-10-29       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.